Does Pregnenolone Enhance Exposure Therapy in Obsessive-Compulsive Disorder? – A Pilot, Interim Report of a Randomized, Placebo-Controlled, Double-Blind Study

Abstract Exposure therapy is an effective cognitive-behavioral treatment for patients with obsessive-compulsive disorder (OCD). However, a further amelioration of symptoms by additional drugs that enhance extinction learning is desirable. An interesting candidate is pregnenolone, which positively modulates NMDA and GABAA receptors in preclinical studies and influences amygdala and prefrontal activity in humans. We present pilot data showing high acceptance and good tolerability of pregnenolone given 2 h before exposure sessions in OCD patients. As per our interim analyses, exposure treatment resulted in significantly improved main outcome parameters, but no effects of pregnenolone vs. placebo pretreatment were detectable thus far.

[1]  E. Storch,et al.  Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder , 2014, Expert review of neurotherapeutics.

[2]  E. Coutinho,et al.  Does D-Cycloserine Enhance Exposure Therapy for Anxiety Disorders in Humans? A Meta-Analysis , 2014, PloS one.

[3]  B. Bradley,et al.  A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. , 2014, The American journal of psychiatry.

[4]  Cheri A. Levinson,et al.  A HIGH‐THROUGHPUT CLINICAL ASSAY FOR TESTING DRUG FACILITATION OF EXPOSURE THERAPY , 2013, Depression and anxiety.

[5]  Anthony P. King,et al.  Allopregnanolone Elevations Following Pregnenolone Administration Are Associated with Enhanced Activation of Emotion Regulation Neurocircuits , 2013, Biological Psychiatry.

[6]  J. Lieberman,et al.  Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence , 2011, Neuroscience.

[7]  Michael Davis,et al.  Pharmacological treatments that facilitate extinction of fear: Relevance to psychotherapy , 2011, NeuroRX.

[8]  Sowmya R. Rao,et al.  Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine. , 2010, Behaviour research and therapy.

[9]  J. Abramowitz.  The Psychological Treatment of Obsessive—Compulsive Disorder , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[10]  M. Hautzinger.  [The Beck Depression Inventory in clinical practice]. , 1991, Der Nervenarzt.

[11]  W. Goodman,et al.  Yale-Brown Obsessive Compulsive Scale (Y-BOCS) , 1991 .